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ABSTRACT

Article Type:

Renal ischemia-reperfusion (RIR) is a pathological condition due to transient restriction of blood
flow to the kidneys, which is followed by the subsequent recovery of perfusion and re-oxygenation.
RIR injury contributes to the progression of renal dysfunction including acute kidney injury (AKI)
in native and renal allograft transplant. The generation of reactive oxygen species (ROS) during
oxidative stress contributes to the occurrence of RIR. Hence, the use of antioxidant compounds can
improve oxidative stress due to RIR. This review highlights herbal antioxidant efficacy against RIR
injury. The findings of this study indicate that antioxidant compounds with herbal origin could
reduce complications due to oxidative stress related to RIR through diminishing lipid peroxidation,
decreased production of malondialdehyde (MDA), apoptosis and increasing antioxidant enzymes
activity. Reducing oxidative stress with the pharmacological approach of antioxidants can be a
desirable target for ameliorating RIR.
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Implication for health policy/practice/research/medical education:

Antioxidants diminish the oxidative damage caused by renal ischemia-reperfusion (RIR) through inhibiting the lipid peroxidation
and increasing the activity of antioxidant enzymes. Hence, targeting the oxidative stress pathway with antioxidants can be a
pharmacological approach to ameliorate RIR injury.
Please cite this paper as: Asgharpour M, Tolouian A, Bhaskar LVKS, Tolouian R, Massoudi N. Herbal antioxidants and renal
ischemic-reperfusion injury; an updated review. J Nephropharmacol. 2021:10(1):e03. DOI: 10.34172/npj.2021.03.

Introduction
Renal ischemia-reperfusion (RIR) is a pathological
condition caused by transient restriction of blood flow to
the kidneys that is followed by the subsequent recovery of
perfusion and re-oxygenation. Under different conditions
RIR injury may be caused by shock, cardiac arrest, sepsis,
surgical interventions, and organ transplantation (1). Acute
kidney injury (AKI) is recognized as a major complication
of RIR, leading to a significant decrease in kidney function
and a concomitant elevated serum creatinine level (2,3).
The occurrence of RIR injuries involves various pathways
such as apoptosis, the production of reactive oxygen
species (ROS), activation of neutrophils, and inflammatory
mediators including cytokines and adhesion molecules
(4,5). Oxidative stress is one of the main events that occur

during RIR, which induces cytotoxic effects; including
DNA damage, proteins oxidation, lipids peroxidation,
production of malondialdehyde (MDA) and induction of
apoptosis (6,7).
Reperfusion following ischemia leads to re-oxygenation,
re-warming and a throwback to aerobic metabolism.
However, the increased renal oxygen concentration in
reperfusion condition can contribute to the production
of ROS (H2O2, •O-2 and •OH), resulting in injury to the
functional and cytoskeletal cellular components (8,9).
RIR also has a significant role in early renal allograft
dysfunction (10). Different strategies to reduce the
complications of RIR injury through ROS scavenging is
depicted in Figure 1 (11). The compounds extracted from
medicinal plants including antioxidants have long been
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Figure 1. Oxidative stress and RIR injury, the role of antioxidants.

used as an alternative to synthetic drugs, due to their easy
accessibility, fewer side effects and economic efficacy (12,
13). It has been documented that the administration of
antioxidants leads to a protective effect against RIR Injury
mediated oxidative injury (14). Although much progress
has been made through the use of animal models, very
few reviews have presented the quantitative synthesis of
the effective antioxidants used against RIR injury (15-18).
In the present review, we summarize the existing evidence
found on the effects of the most important antioxidant
compounds used for ischemia reperfusion (IR) induced
renal injury (Figure 2). We also specifically highlighted
some of lesser known antioxidants on this subject (Table 1).
Method of study
Relevant articles, published between 2004 to 2019, were
searched from different databases such as the Google
Scholar, PubMed/Medline, Web of Science, Scopus,
Embase, EBSCO and Directory of Open Access Journals
(DOAJ) using search terms of “renal ischemia-reperfusion”,
“antioxidant”, “reactive oxygen species”, “oxidative stress”,
“free radicals”, and “medicinal plants”.
Curcumin
Curcumin is a natural polyphenol derived from the dried
rhizome of Curcuma longa (19). This compound is widely
used in Asian countries due to its antimicrobial, antiinflammatory, antimutagenic, anticancer and antioxidant
properties (20). Curcumin can neutralize various types of
free radicals including ROS and reactive nitrogen species
(RNS), and also enhances the activity of antioxidant
enzymes such as glutathione (GSH), catalase (CAT)
and superoxide dismutase (SOD) (21). Furthermore,
curcumin reduces the production of noxious oxidants
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and contributes to ameliorating tubular necrosis (22).
It has been proven that curcumin exhibits remarkable
protective effects against RIR injury (23, 24). It has been
demonstrated that curcumin up-regulates adaptor protein
(APPL1) and subsequently suppresses phosphorylation of
Akt pathway thereby protecting kidneys from IR-induced
AKI (25). Experimental studies in rats with RIR showed
that curcumin can ameliorate renal tubular injury through
inhibiting iNOS/NO/cGMP/PKG signaling pathway (26).
In addition to this, curcumin-carrying nanoparticles
showed protective effects in human renal proximal tubular
(HK-2) cells exposed to RIR by decreasing apoptosis,
ROS level, MDA content, inhibiting the expression of Bax
protein and caspase-3 and enhancing the expression of
Bcl-2 and SOD activity (27). Moreover, the renoprotective
effect of curcumin in RIR injury is related to the
suppression of NF-KB and activation of the JAK2/STAT3
signaling pathway (28).
Luteolin
Luteolin (3′, 4′, 5, 7-tetrahydroxyflavone) is a flavone
compound present in fruits and vegetables. Luteolin
biological activities include anti-inflammatory, anticancer
and antioxidative activities (29). Several studies have
indicated that treatment with luteolin ameliorates renal
complications such as renal anemia, diabetic nephropathy
and RIR injury (30, 31). In vivo and in vitro studies
showed that luteolin inhibited xanthine oxidase (XO)
and nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase activity during IR event (32). Luteolin,
as an anti-inflammatory and antioxidant agent, showed
nephroprotective effects in mice with RIR (33). These
nephroprotective effects were evident by marked elevation
in SOD and CAT levels and concomitant decrease in TNFhttp://www.jnephropharmacology.com
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Figure 2. Chemical structure of studied antioxidants; (a) Melatonin, (b) Luteolin, (c) Gallic acid, (d) Silymarin, (e) Resveratrol, (f)
Curcumin, (g) Quercetin, (h) Apocynin, (i) Berberine, (j) Rutin, (k) Vitamin C.

α, IL -1β, IL-6 levels (33). Further, treatment with luteolin
upregulated Bcl-2 expression and reduced Bax expression,
indicating that luteolin reduced the level of apoptosis in
renal tissue (34).
Melatonin
Melatonin (N-acetyl-5-methoxytryptamine) is an
endogenous hormone with multiple physiological and
cellular functions. Several lines of evidence indicate the
presence of melatonin in plants as an antioxidant (35).
Melatonin plays a major role in several pathological
conditions;
including
cardiovascular
diseases,
neurodegenerative diseases, metabolic syndrome,
infection and others (36). Different studies have illustrated
that melatonin, as an attractive therapeutic agent, can
ameliorate ischemic/reperfusion (IR)-induced disorders
in membrane structure, biogenesis, mitochondrial redox
state, mitophagy and related dynamics (37-39). Melatonin
protects against RIR injury through its antioxidative
effects as evidenced by the increased levels of antioxidative
enzymes such as glutathione peroxides (GPX, GSH), CAT,
SOD and neutralizing hydroxyl radicals. Interestingly,
it scavenges free radicals more effectively than vitamin
E (40). It has been presented that melatonin as a key
modulator of cell survival, greatly increases activation of
AMP-activated protein kinase (AMPK) that stimulates
antioxidative enzymes and contributes to antioxidant
defense (41). In addition to this, melatonin therapy
improved RIR injury by preventing cell apoptosis,
oxidative stress and histopathological lesions in diabetic
rats with RIR injury (42). Furthermore, melatonin reduced
expressions of nuclear factor erythroid 2-related factor 2
(Nrf2), silent information regulator 2 associated protein
1 (SIRT1) and heme oxygenase-1 (HO-1) by activating
SIRT1/Nrf2/HO-1 signaling pathway (42). Melatonin also
http://www.jnephropharmacology.com

reduced cell injury due to RIR via reducing endoplasmic
reticulum stress and Akt pathway (43).
Resveratrol
Resveratrol (3,5,4′-trihydroxystilbene) is a plant-derived
molecule with potent antioxidant properties. Treatment
with this polyphenol ameliorated diabetic nephropathy
and renal dysfunction by reducing creatinine, urea,
albumin levels and albumin to creatinine ratio (44).
Studies using animal models showed that resveratrol,
through its antioxidant effect or SIRT1 activation,
ameliorated IR induced AKI (45). A recent study suggested
that resveratrol administration at a dose of 60 mg/kg for
three weeks improved levels of GSH and MDA as well
as renal tissue injury in rats with RIR (46). Although
the nephroprotective mechanisms of resveratrol in RIR
injury are not fully clarified, some studies indicate that
the resveratrol in combination with leptin, modulate the
JAK/STAT signaling pathway and ameliorates RIR injury
(47). Additional studies suggest that the combination
of resveratrol and N-methyl-d-aspartate receptor
inhibitor (DAP5) may prevent RIR injury by suppressing
inflammation processes and apoptosis via NF-κB and
CaMK/DAPK/AKT/NMDA pathways (48). In this
context, resveratrol has been demonstrated to be involved
in the recovery of renal function after RIR injury through
the Nrf2/TLR4/NF-κB pathway (49).
Vitamin C
Vitamin C or ascorbic acid is one of the water-soluble
vitamins, that has the ability to protect cell membranes
against lipid peroxidation by acting as a ROS scavenger
(50). Vitamin C can neutralize •O-2 in the cytosol and
extracellular matrix and scavenge peroxynitrite to inhibit
the formation of nitrotryphophan, nitrotyrosine and
Journal of Nephropharmacology, Volume 10, Issue 1, 2021
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Table 1. The renoprotective effects of specific antioxidants against RIR injury

Antioxidant
compounds
Oleanolic acid
Astaxanthin

Model

Ischemia time

Reperfusion
time

Wistar rat

45 min

6h

Mice

45 min

Outcomes

Reference

• Stabilization of Nrf2/GCLc signaling
• Preservation of the GSH level

(15)

-

• Reduction of tubular injury, apoptosis, necrosis and
inflammation via scavenging free radicals

(16)

• Improvement of morphological alterations and renal
dysfunction
• Reduced TBARS levels and
• Increased renal antioxidant enzymes

(87)

• Reduction of ROS generation
• Inhibition of neutrophils infiltration and apoptosis
• Reduction of TNF- α and ICAM-1 expression

(88)

• Prevention of apoptosis
• Diminution of TNF-α

(89)

Sprague-Dawley
rat

45 min

24 h

C57BL/6 mice

50 min

-

Magnolol

Sprague-Dawley
rat

60 min

24 h

Protocatechuic
acid

Sprague-Dawley
rat

45 min

3h

Syringic acid

Wistar-Albino rat

30 min

1h

• Prevention of apoptosis
• Reduction of TOS, OSI and MDA
• Amelioration of GPX activity

(91)

Ukrain

Sprague-Dawley
rat

30 min

2h

• Reduction of apoptosis and oxidative stress
• Regulation of the TOS/TAS activity

(92)

Tyrosol

Sprague–Dawley
rat

45 min

6h

• Inhibition of iNOS-mediated oxidative stress

(93)

(94)

Naringin

Ligustrazine

• Reduction of kidney and serum MDA, TNF-α level
• Improvement of total antioxidant status in serum and
kidney

(90)

Sprague-Dawley
rat

45 min

-

• Improvement of histopathology alteration and renal
dysfunction
• Reduction of oxidative stress and apoptosis through
the Akt/mTOR/4EBP1 pathway

Sprague-Dawley
rat

60 min

-

• Prevention of peritubular capillary endothelium
damages
• Improvement of the renal hypoxia

(95)

Salvianolic acid B

Sprague-Dawley
rat

50 min

48 h

• Reduction of the inflammatory process and oxidative
stress via PI3K/Akt signaling pathway

(96)

Apigenin

Sprague-Dawley
rat

45 min

-

• Prevention of apoptosis in vitro and in vivo through
PI3K/Akt pathway
• Improvement of histopathology alteration of kidney

(97)

Baicalin

Wistar rat

45 min

-

• Decreased oxidative stress
• Inhibition of proinflammatory responses and
apoptosis through mitochondrial stress and TLR2/4
pathway

(98)

Wistar-Albino rats

45 min

6h

• Decreased MDA, blood urea nitrogen creatinine and
NO levels,
• Improvement of histopathology alteration of kidney

(99, 100)

Salvianolic acid A

Lycopene

nitrated lipids (51). This antioxidant compound reduces
oxidative stress and improves cellular function by inhibiting
inflammation due to IR injury (52). Furthermore, vitamin
C supplementation promoted renal nitric oxide (NO),
GSH and SOD, leading to the preservation of kidney
function and renal arterial reactivity against RIR (53).
It has been revealed that the administration of vitamin
C reduced RIR-induced renal injury in rats by reversing
elevated serum creatinine and blood urea nitrogen (54).
4

Journal of Nephropharmacology, Volume 10, Issue 1, 2021

Berberine
Berberine is an isoquinoline alkaloid present in some
medicinal plants, including barberry, golden thread,
Oregon grape, tree turmeric and Amur cork tree (55). In
vitro and in vivo studies have demonstrated that berberine
possesses protective effects in IR injury (56, 57). According
to a recent study, berberine administration at the doses
of 100 and 150 mg ameliorated RIR in diabetic rats via
its anti-apoptotic, anti-inflammatory and antioxidant
http://www.jnephropharmacology.com
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properties (58). Further, this compound improved
histopathological lesions and kidney dysfunction through
decreased creatinine and blood urea nitrogen levels and
normalized intracellular ion levels via enhancing the Ca2+ATPase and Na+/K+-ATPase levels (58). In addition, in
rats with RIR injury, berberine effectively improved renal
function by exhibiting anti-apoptotic response through
down-regulating Bax expression and upregulating Bcl-2
expression (59). Anti-apoptotic effect of berberine is also
associated with the activation of the phosphatidylinositol
3-kinase/Akt signaling pathway and induction of Nrf2
that results in the protection of renal tubular cells (60).
Quercetin
Quercetin is a bioflavonoid compound with a high
antioxidant property that has a protective effect against
IR injury. This compound scavenges free radicals and
inhibits lipid peroxidation (61). It has been noted that
quercetin, in rats with RIR injury, mitigated oxidative
stress by reducing MDA level and increasing GSH level as
well as inhibiting endothelial nitric oxide synthase (eNOS)
and NF-κB (62). Additionally, this flavonoid can stimulate
AMPK activation by AMPK-regulated autophagy pathway
and protect renal cells against IR injury in vivo and in vitro
(63).
Rutin
Rutin is a flavonol found in plants such as apples, tea,
passion flower and buckwheat (64). Several studies in
experimental models have illustrated that the rutin has
potent nephroprotective activity (65,66). It has been
demonstrated that rutin suppresses the pathogenesis of RIR
through its radical scavenging activity. This antioxidant
can remarkably prevent MDA production, enhance GSH
content and manganese superoxide dismutase (MnSOD)
activity in the RIR rats (67). Pretreatment with rutin
showed beneficial effects against RIR by improving the
oxidative status and diminishing cGMP level in the
kidneys. Moreover, rutin prevents kidney dysfunction
during RIR, through its potent inducible NOS (iNOS)
inhibiting activity (68).
Silymarin
Silymarin is a polyphenolic compound extracted from
Silybum marianum plant. Several in vivo experimental
models of diabetes and drug induced nephrotoxicity have
investigated the effects of silymarin (69,70). Treatment
with silymarin could reduce NO level, protein carbonyl
and serum and tissue MDA in RIR rats indicating its
antioxidant property against RIR (11). During RIR
injury, silymarin pretreatment improved kidney function
by reducing creatinine and blood urea nitrogen levels,
inflammatory cytokines and necrosis of renal tubular
cells (71). Further, treatment with silymarin increased
Bcl-2 expression and decreased Bax expression during the
http://www.jnephropharmacology.com

recovery from RIR injury. In addition to this, a combination
of silymarin and palmitoylethanolamide significantly
decreased renal failure due to IR via suppressing NF-κB
and apoptosis pathways (72).
Rosmarinic acid
Rosmarinic acid is a polyphenol compound present in
plants of Rosmarinus officinalis L, Origanum vulgare,
Ocimum basilicum, Salvia officinalis and Melissa officinalis
(73). Different studies have revealed the pharmacological
and biological activities of rosmarinic acid including
anticancer, anti-inflammatory, antidiabetic, antibacterial,
immunomodulatory and antioxidant (73,74). Rosmarinic
acid has been illustrated to have a beneficial impact
against nephrotoxicity (75). However, very few studies are
available concerning rosmarinic acid’s effect on IR injury.
For instance, Ozturk et al, one of the few available, found
that rosmarinic acid diminishes both the tubular and the
glomerular injury in kidney of IR rats through reduction
of oxidative stress and increase of antioxidant enzyme
activities such as SOD and GPX (76).
Gallic acid
Gallic acid (GA) or 3,4,5 -trihydroxybenzoic acid is a
phenolic acid compound with antioxidant characteristics
and is found in natural products including green tea, grapes,
pineapple and other plants (77). It has been demonstrated
that GA pretreatment mitigates renal tubular damage
in RIR rats by affecting antioxidant enzymes (78). It is
also noted that GA offered renoprotective effect against
RIR induced AKI through the activation of peroxisome
proliferator-activated receptor gamma (PPAR-γ) (79).
Apocynin
Apocynin was first extracted from the roots of Apocynum
cannabinum and was used as a medicine for cardiovascular
diseases (80). Recently, it has been presented that apocynin
has a nephroprotective potential in many models of IR (81,
82). Treatment with apocynin ameliorates renal function
and antioxidant status in RIR rats via modulating the level
of zinc and enhancing expression of metallothionein,
which leads to a reduction of the level of IL-6, MDA, TNF-α
and increment the SOD activity (83). Apocynin alone,
or in combination with allopurinol, can reduce the IR
induced renal dysfunction through inhibition of NADPH
oxidase. In fact, inhibition of NADPH oxidase diminishes
the formation of •O-2, thereby reducing oxidative stress
during IR (84). Furthermore, apocynin contributes to
mitigating histological lesions of RIR through glomerular
damage, tubular necrosis and apoptosis as well as levels
of blood urea nitrogen, creatinine and myeloperoxidase
(85). Moreover, apocynin stimulates expression of
Srchomology-2 domain-containing phosphatase-1 and
ameliorates nitroso-redox unbalance to protect the kidney
against IR injury (86).
Journal of Nephropharmacology, Volume 10, Issue 1, 2021
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Discussion
Oxidative stress is identified as one of the important
pathophysiological factors in IR injury. Free radicals
produced during the oxidative stress process play a vital
role in the stimulation of IR injury in different organs,
including the kidney (101). Increased oxidative markers
such as RNS and ROS may lead to deleterious impacts
on the cellular structure through induction of necrosis
or apoptosis (102). Moreover, inflammation pathways
intensify oxidative stress, therefore the over-generation
of pro-inflammatory cytokines induce tissue and cellular
injury via inflammatory cell infiltration (103).
Recently, medicines such as diuretics and atorvastatin
have been used to improve RIR, however, these medications
don’t have considerable suppressive effects against renal
injury (104). It has presented that potent antioxidant
ingredients with herbal origin can positively protect
the kidney against IR injury (105). In fact, antioxidants
such as alkaloids, vitamins, phenolics and flavonoids can
significantly scavenge free radicals and ameliorate the
function of antioxidant enzymes and lipid peroxidation in
oxidative stress-related RIR (106).
Antioxidants diminish damage due to RIR through
different mechanisms. For instance, Jiang et al reported
that pretreatment with oxymatrine, an alkaloid
compound, up-regulated the expression of HO-1 through
the stimulation of the Nrf2 pathway and thereby protected
kidney by improving RIR injury (107). The protective
effect of N-acetylcysteine on RIR may also be related
to the Nrf2 pathway (108). Li et al in a recent study
investigated the renoprotective effect of tea polyphenols
on IR-induced renal injury, as well as its renoprotective
mechanism. Their results demonstrated that pretreatment
with tea polyphenols before induction of ischemia, reduce
inflammatory cell infiltration and renal tubular injury
through suppressing the TLR4/NF-κB p65 signaling
pathway in RIR rats (109). In addition, PI3K/Akt, JAK/
STAT signaling (47,96) and other pathways related to
the regulation of apoptosis and NF-κB pathways were
considered in many studies (49,72). Even some herbs, such
as Allium sativum (garlic), have been shown to decrease
inflammatory markers in dialysis patients, and might be
appropriate interventions in future studies in RIR (110).
Conclusion
Altogether, this review adds further evidence to ongoing
discussion on the benefits of herbal antioxidants in the
treatment of renal injury. The evidence from this study
implies that different antioxidants diminish the oxidative
damage caused by RIR through inhibiting the lipid
peroxidation and increasing the activity of antioxidant
enzymes. Therefore, targeting the oxidative stress pathway
with antioxidants can be a pharmacological approach to
ameliorate RIR injury. However, it is recommended to
carry out future studies in this field.
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